Insight Molecular Diagnostics Inc. IMDX 深 沪
已收盘 10-09 16:00:00 美东时间
3.37
+0.090
+2.74%
华盛通- 最 高3.441
- 今 开3.29
- 成交量 15.64万股
- 最 低 3.19
- 昨 收 3.28
- 总市值 1.10亿
- 52周最高 8.51
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 2.42
- 委 比 9.20%
- 总股本 3272.43万
- 历史最高 204.80
- 量 比 0.47
- 振 幅 7.65%
- 历史最低 1.922
- 每 手 1
- 风险率 1.17%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Insight Molecular Diagnostics Revises Chronix Royalty Agreement Terms
Insight Molecular Diagnostics ( ($IMDX) ) has issued an announcement. Insight M...
09-22 04:59
iMDx Amends Chronix Merger Agreement, Replacing Ongoing 10% CNI Monitor Royalty With 10% Sale Payment Upon CNI Monitor Sale
As previously reported, Insight Molecular Diagnostics Inc. (the "Company" or "iMDx") entered into an Agreement and Plan of Merger dated February 2, 2021, amended February 23, 2021, and amended and restated as of April 15, 2021 (as amended and restated, the "Merger Agreement"), by and among the Compa...
09-22 04:08
iMDx to Participate in Lake Street 10th Annual Best Ideas Growth “BIG10” Conference
Insight Molecular Diagnostics Inc. (IMDX) announced its participation in the Lake Street Capital Markets 10th Annual Best Ideas Growth "BIG10" Conference on September 10, 2026, in New York. CEO Josh Riggs and CFO Andrea James will attend, offering one-on-one meetings with investors. The event will take place at the Metropolitan Club. Investors interested in meeting IMDX management should contact their Lake Street sales representative. Insight Mol...
09-02 12:00
美股大行评级 | 首予买入！Jersey Mike's获13家大行评级；大摩、富国银行齐上调迈威尔科技目标价，最高升至310美元
今日重点评级关注：Truist Securities：维持CoreWeave"买入"评级，目标价从155美元升至165美元；百德：维持亚德诺"跑赢大市"评级，目标价从450美元升至675美元
08-25 11:47
LUCID CAPITAL MARKETS Initiates Coverage On Insight Molecular with Buy Rating, Announces Price Target of $8
LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Insight Molecular (NASDAQ:IMDX) with a Buy rating and announces Price Target of $8.
08-24 22:50
美股大行评级 | 潜在涨幅167.3%！HC Wainwright上调Tango Therapeutics目标价至68美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Tango Therapeutics"买入"评级，目标价从66美元升至68美元；康托·菲茨杰拉德：维持Duos Technologies Group"超配"评级，目标价从26美元升至27美元
08-19 08:37
Insight Molecular Diagnostics To Host Virtual KOL Event On August 17 To Discuss GraftAssure Platform Leveraging Digital PCR Technology For Reliable dd-cfDNA Results In Transplanted Organ Health Monitoring
Insight Molecular Diagnostics Inc., (NASDAQ:IMDX), (iMDx), today announced that it will host a virtual key opinion leader (KOL) event on Monday, August 17, 2026 at 11AM ET featuring Max Jacob Liebo, MD (Loyola University Medical Center), who will join Nick Ioannou, MD, MHA (iMDx VP Medical Affairs) ...
08-12 04:17
Insight Molecular Diagnostics to Host Virtual KOL Event on August 17, 2026: Moving Toward In-House Heart Transplanted Organ Rejection Testing
Insight Molecular Diagnostics Inc. (iMDx) will host a virtual KOL event on August 17, 2026, featuring Max Jacob Liebo, MD, Nick Ioannou, MD, MHA, and Josh Riggs to discuss the GraftAssure platform, which uses digital PCR technology for reliable dd-cfDNA results in transplant organ monitoring. The event will cover the FDA-reviewed GraftAssureDx test for kidney transplant rejection and its implications for heart transplants. iMDx aims to bring test...
08-11 20:05
CORRECTION: Insight Molecular Q2 Adj. EPS $(0.23) Beats $(0.24) Estimate, Sales $239.000K Miss $437.500K Estimate
Insight Molecular (NASDAQ:IMDX) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.24) by 4.17 percent. This is a 23.33 percent increase over losses of $(0.30) per share from the same period last year. The company reported quarterly sales of $239.000 thou...
08-11 06:24
iMDx to Release Second Quarter Results on August 10, 2026 and Attend Needham Virtual MedTech & Diagnostics 1x1 Conference
Insight Molecular Diagnostics Inc. (iMDx) will report its second quarter 2026 financial results after market close on August 10, 2026, followed by a live Zoom webinar at 2:00 pm PT / 5:00 pm ET. A registration link for the webinar is provided. An archived replay will be available on the company’s website. Additionally, CEO Josh Riggs and CFO Andrea James will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on A...
08-04 11:00
